No shared counterparties.
| Stage | BC | % of rev | CMI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $9.5B | 100.00% | CMI ×6.07 |
| Gross profit | $438M | 28.10% | $2.5B | 26.07% | BC +2.0pp |
| Operating income | $129M | 8.31% | $1.3B | 13.52% | CMI +5.2pp |
| Pre-tax income | $106M | 6.83% | $1.3B | 13.67% | CMI +6.8pp |
| Net income | $110M | 7.05% | $968M | 10.24% | CMI +3.2pp |
| Stage | BC | CMI | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $9.5B100.00% | CMI ×6.07 |
| Gross profit | 28.10%$438M | 26.07%$2.5B | BC +2.0pp |
| Operating income | 8.31%$129M | 13.52%$1.3B | CMI +5.2pp |
| Pre-tax income | 6.83%$106M | 13.67%$1.3B | CMI +6.8pp |
| Net income | 7.05%$110M | 10.24%$968M | CMI +3.2pp |